Chemical activators of Svs7 include a range of compounds that can enhance the protein's function through various cellular signaling pathways. 6-Benzylaminopurine can activate Svs7 by enhancing its affinity for ATP, which is a common mechanism of action for the activation of many proteins. Similarly, Forskolin raises the levels of cAMP within the cell, which then activates protein kinase A (PKA). PKA is known to phosphorylate a wide array of target proteins, including Svs7, thus leading to its activation. Phorbol 12-myristate 13-acetate (PMA), another chemical activator, functions by activating protein kinase C (PKC), a kinase which can phosphorylate Svs7, resulting in its activation. Ionomycin, by increasing intracellular calcium levels, could activate calcium-dependent protein kinases that then target Svs7 for activation. SB 216763 indirectly activates Svs7 by stimulating the Wnt/β-catenin signaling pathway, which is involved in the regulation of protein phosphorylation processes that can activate Svs7.
6-Bromoindirubin-3'-oxime (BIO) inhibits GSK-3β, a kinase that when active, can phosphorylate and inactivate various proteins. The inhibition of GSK-3β by BIO can prevent the phosphorylation of proteins that otherwise would inhibit Svs7, thereby leading to its activation. Dibutyryl-cAMP, as a cAMP analog, activates PKA, which can then phosphorylate Svs7. Okadaic acid's role in inhibiting protein phosphatases 1 and 2A may result in the accumulation of phosphorylated Svs7, which is the active form of the protein. Anisomycin activates the MAP kinase pathways that can lead to the phosphorylation and subsequent activation of Svs7. Inhibition of PI3K by LY294002 leads to the activation of AKT, a kinase that can phosphorylate and activate Svs7. PD98059, through the inhibition of MEK, can cause the compensatory activation of alternative MAPK pathways that can lead to Svs7 activation. Lastly, Y-27632 inhibits ROCK, which can lead to changes in the actin cytoskeleton and subsequent activation of Svs7 through altered cellular dynamics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
6-Benzylaminopurine | 1214-39-7 | sc-202428 sc-202428A | 1 g 5 g | $20.00 $51.00 | ||
6-Benzylaminopurine activates Svs7 by mimicking adenine derivatives, potentially enhancing Svs7's affinity for ATP, which is often required for protein activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can lead to activation of protein kinase A (PKA) and subsequent phosphorylation and activation of Svs7. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which may phosphorylate Svs7, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin raises intracellular calcium levels, which can activate calcium-dependent protein kinases, potentially resulting in the activation of Svs7. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
SB 216763 activates the Wnt/β-catenin pathway, which may lead to the phosphorylation of proteins, including Svs7, thereby enhancing its activation. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $57.00 $184.00 $867.00 | 10 | |
6-Bromoindirubin-3'-oxime (BIO) inhibits GSK-3β, which may prevent the phosphorylation of proteins that inhibit Svs7, leading to its activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, can activate PKA, which may subsequently phosphorylate and activate Svs7. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic acid inhibits protein phosphatases 1 and 2A, which may lead to an increase in the phosphorylated, active form of Svs7. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin activates MAP kinase pathways, which can lead to the phosphorylation and activation of several proteins, including potentially Svs7. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, leading to activation of downstream AKT, which can phosphorylate and activate various proteins, potentially including Svs7. | ||||||